Copyright Reports & Markets. All rights reserved.

Global Microneedle-based Drug Delivery System Market Research Report 2021

Request for Sample of this report
Buy now

1 Microneedle-based Drug Delivery System Market Overview

  • 1.1 Product Overview and Scope of Microneedle-based Drug Delivery System
  • 1.2 Microneedle-based Drug Delivery System Segment by Type
    • 1.2.1 Global Microneedle-based Drug Delivery System Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Hollow Microneedle Technology
    • 1.2.3 Solid Microneedle Technology
    • 1.2.4 Dissolving Microneedles Technology
  • 1.3 Microneedle-based Drug Delivery System Segment by Application
    • 1.3.1 Microneedle-based Drug Delivery System Sales Comparison by Application: (2021-2027)
    • 1.3.2 Drug Delivery
    • 1.3.3 Vaccine Delivery
    • 1.3.4 Other
  • 1.4 Global Microneedle-based Drug Delivery System Market Size Estimates and Forecasts
    • 1.4.1 Global Microneedle-based Drug Delivery System Revenue 2016-2027
    • 1.4.2 Global Microneedle-based Drug Delivery System Sales 2016-2027
    • 1.4.3 Microneedle-based Drug Delivery System Market Size by Region: 2016 Versus 2021 Versus 2027

2 Microneedle-based Drug Delivery System Market Competition by Manufacturers

  • 2.1 Global Microneedle-based Drug Delivery System Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Microneedle-based Drug Delivery System Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Microneedle-based Drug Delivery System Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Microneedle-based Drug Delivery System Manufacturing Sites, Area Served, Product Type
  • 2.5 Microneedle-based Drug Delivery System Market Competitive Situation and Trends
    • 2.5.1 Microneedle-based Drug Delivery System Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Microneedle-based Drug Delivery System Players Market Share by Revenue
    • 2.5.3 Global Microneedle-based Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Microneedle-based Drug Delivery System Retrospective Market Scenario by Region

  • 3.1 Global Microneedle-based Drug Delivery System Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Microneedle-based Drug Delivery System Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Microneedle-based Drug Delivery System Market Facts & Figures by Country
    • 3.3.1 North America Microneedle-based Drug Delivery System Sales by Country
    • 3.3.2 North America Microneedle-based Drug Delivery System Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Microneedle-based Drug Delivery System Market Facts & Figures by Country
    • 3.4.1 Europe Microneedle-based Drug Delivery System Sales by Country
    • 3.4.2 Europe Microneedle-based Drug Delivery System Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Microneedle-based Drug Delivery System Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Microneedle-based Drug Delivery System Sales by Region
    • 3.5.2 Asia Pacific Microneedle-based Drug Delivery System Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Microneedle-based Drug Delivery System Market Facts & Figures by Country
    • 3.6.1 Latin America Microneedle-based Drug Delivery System Sales by Country
    • 3.6.2 Latin America Microneedle-based Drug Delivery System Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Microneedle-based Drug Delivery System Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Microneedle-based Drug Delivery System Sales by Country
    • 3.7.2 Middle East and Africa Microneedle-based Drug Delivery System Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Microneedle-based Drug Delivery System Historic Market Analysis by Type

  • 4.1 Global Microneedle-based Drug Delivery System Sales Market Share by Type (2016-2021)
  • 4.2 Global Microneedle-based Drug Delivery System Revenue Market Share by Type (2016-2021)
  • 4.3 Global Microneedle-based Drug Delivery System Price by Type (2016-2021)

5 Global Microneedle-based Drug Delivery System Historic Market Analysis by Application

  • 5.1 Global Microneedle-based Drug Delivery System Sales Market Share by Application (2016-2021)
  • 5.2 Global Microneedle-based Drug Delivery System Revenue Market Share by Application (2016-2021)
  • 5.3 Global Microneedle-based Drug Delivery System Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 3M
    • 6.1.1 3M Corporation Information
    • 6.1.2 3M Description and Business Overview
    • 6.1.3 3M Microneedle-based Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 3M Product Portfolio
    • 6.1.5 3M Recent Developments/Updates
  • 6.2 Zosano Pharma
    • 6.2.1 Zosano Pharma Corporation Information
    • 6.2.2 Zosano Pharma Description and Business Overview
    • 6.2.3 Zosano Pharma Microneedle-based Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Zosano Pharma Product Portfolio
    • 6.2.5 Zosano Pharma Recent Developments/Updates
  • 6.3 Becton-Dickinson（BD）Technologies
    • 6.3.1 Becton-Dickinson（BD）Technologies Corporation Information
    • 6.3.2 Becton-Dickinson（BD）Technologies Description and Business Overview
    • 6.3.3 Becton-Dickinson（BD）Technologies Microneedle-based Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Becton-Dickinson（BD）Technologies Product Portfolio
    • 6.3.5 Becton-Dickinson（BD）Technologies Recent Developments/Updates
  • 6.4 Nanopass Technologies
    • 6.4.1 Nanopass Technologies Corporation Information
    • 6.4.2 Nanopass Technologies Description and Business Overview
    • 6.4.3 Nanopass Technologies Microneedle-based Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Nanopass Technologies Product Portfolio
    • 6.4.5 Nanopass Technologies Recent Developments/Updates
  • 6.5 Corium
    • 6.5.1 Corium Corporation Information
    • 6.5.2 Corium Description and Business Overview
    • 6.5.3 Corium Microneedle-based Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Corium Product Portfolio
    • 6.5.5 Corium Recent Developments/Updates
  • 6.6 Valeritas
    • 6.6.1 Valeritas Corporation Information
    • 6.6.2 Valeritas Description and Business Overview
    • 6.6.3 Valeritas Microneedle-based Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Valeritas Product Portfolio
    • 6.6.5 Valeritas Recent Developments/Updates
  • 6.7 Nitto
    • 6.6.1 Nitto Corporation Information
    • 6.6.2 Nitto Description and Business Overview
    • 6.6.3 Nitto Microneedle-based Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Nitto Product Portfolio
    • 6.7.5 Nitto Recent Developments/Updates
  • 6.8 Microdermics
    • 6.8.1 Microdermics Corporation Information
    • 6.8.2 Microdermics Description and Business Overview
    • 6.8.3 Microdermics Microneedle-based Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Microdermics Product Portfolio
    • 6.8.5 Microdermics Recent Developments/Updates
  • 6.9 TheraJect
    • 6.9.1 TheraJect Corporation Information
    • 6.9.2 TheraJect Description and Business Overview
    • 6.9.3 TheraJect Microneedle-based Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 TheraJect Product Portfolio
    • 6.9.5 TheraJect Recent Developments/Updates
  • 6.10 Vaxxas
    • 6.10.1 Vaxxas Corporation Information
    • 6.10.2 Vaxxas Description and Business Overview
    • 6.10.3 Vaxxas Microneedle-based Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Vaxxas Product Portfolio
    • 6.10.5 Vaxxas Recent Developments/Updates
  • 6.11 Lohmann Therapie-Systeme AG
    • 6.11.1 Lohmann Therapie-Systeme AG Corporation Information
    • 6.11.2 Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Description and Business Overview
    • 6.11.3 Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Lohmann Therapie-Systeme AG Product Portfolio
    • 6.11.5 Lohmann Therapie-Systeme AG Recent Developments/Updates

7 Microneedle-based Drug Delivery System Manufacturing Cost Analysis

  • 7.1 Microneedle-based Drug Delivery System Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Microneedle-based Drug Delivery System
  • 7.4 Microneedle-based Drug Delivery System Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Microneedle-based Drug Delivery System Distributors List
  • 8.3 Microneedle-based Drug Delivery System Customers

9 Microneedle-based Drug Delivery System Market Dynamics

  • 9.1 Microneedle-based Drug Delivery System Industry Trends
  • 9.2 Microneedle-based Drug Delivery System Growth Drivers
  • 9.3 Microneedle-based Drug Delivery System Market Challenges
  • 9.4 Microneedle-based Drug Delivery System Market Restraints

10 Global Market Forecast

  • 10.1 Microneedle-based Drug Delivery System Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Microneedle-based Drug Delivery System by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Microneedle-based Drug Delivery System by Type (2022-2027)
  • 10.2 Microneedle-based Drug Delivery System Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Microneedle-based Drug Delivery System by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Microneedle-based Drug Delivery System by Application (2022-2027)
  • 10.3 Microneedle-based Drug Delivery System Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Microneedle-based Drug Delivery System by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Microneedle-based Drug Delivery System by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Hollow Microneedle Technology
    Solid Microneedle Technology
    Dissolving Microneedles Technology

    Segment by Application
    Drug Delivery
    Vaccine Delivery
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    3M
    Zosano Pharma
    Becton-Dickinson（BD）Technologies
    Nanopass Technologies
    Corium
    Valeritas
    Nitto
    Microdermics
    TheraJect
    Vaxxas
    Lohmann Therapie-Systeme AG

    Buy now